‘No basis for concerns over SMA generic drug,’ says technical panel chief

Kerala plans to procure Natco's legally approved generic spinal muscular atrophy drug, costing eight thousand rupees instead of five lakh twenty thousand, saving millions annually despite political row and safety objections.
Read the full report on Onmanorama
Story file
- Section
- India
- Places
- Kerala
- First reported by
- Onmanorama
- Reporter
- manoj kadambad
- Published
- Sunday, 25 October 2026, 1:22 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Onmanorama with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.





